| Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) (NCT00623779) | AstraZeneca | 2007-10-01 |
| Symbicort Rapihaler Therapeutic Equivalence Study (NCT00536731) | AstraZeneca | 2007-09-01 |
| Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour (NCT00503204) | AstraZeneca | 2007-09-01 |
| Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets (NCT00536796) | AstraZeneca | 2007-09-01 |
| Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients (NCT00573742) | AstraZeneca | 2007-09-01 |
| A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise (NCT00528372) | AstraZeneca | 2007-09-01 |
| Liver Safety Under Upfront Arimidex vs Tamoxifen (NCT00537771) | AstraZeneca | 2007-09-01 |
| Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma (NCT00536913) | AstraZeneca | 2007-09-01 |
| Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics) (NCT00690612) | AstraZeneca | 2007-09-01 |
| A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes (NCT00516074) | AstraZeneca | 2007-09-01 |
| A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes (NCT00612794) | AstraZeneca | 2007-09-01 |
| Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients (NCT00539331) | AstraZeneca | 2007-09-01 |
| Drug Interaction Study Between AZD3480 and Warfarin (NCT00689637) | AstraZeneca | 2007-09-01 |
| A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone (NCT00528879) | AstraZeneca | 2007-09-01 |
| Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer (NCT00668083) | AstraZeneca | 2007-09-01 |
| Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide® (NCT00542880) | AstraZeneca | 2007-09-01 |
| Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer (NCT00515866) | AstraZeneca | 2007-08-01 |
| A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) (NCT00520572) | AstraZeneca | 2007-08-01 |
| Quetiapine in Postpartum Depression (NCT00681668) | AstraZeneca | 2007-08-01 |
| An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes (NCT00516048) | AstraZeneca | 2007-08-01 |
| Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia (NCT00528905) | AstraZeneca | 2007-08-01 |
| Generalized Anxiety Disorder Adjunct Study (NCT00534599) | AstraZeneca | 2007-08-01 |
| 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (NCT00525824) | AstraZeneca | 2007-08-01 |
| Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID (NCT00542789) | AstraZeneca | 2007-08-01 |
| A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) (NCT00533260) | AstraZeneca | 2007-07-01 |
| A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice (NCT00505388) | AstraZeneca | 2007-07-01 |
| LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS) (NCT00567619) | AstraZeneca | 2007-07-01 |
| AZD6765 for Treatment Resistant Depression (NCT00491686) | AstraZeneca | 2007-07-01 |
| Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) (NCT00486265) | AstraZeneca | 2007-07-01 |
| Effects of Single Oral Dose Dapagliflozin QT Study (NCT00688493) | AstraZeneca | 2007-07-01 |
| Diabetic Under 70 (Diabetics Below 70) (NCT00516204) | AstraZeneca | 2007-07-01 |
| Symbicort SMART (Symbicort Maintenance And Reliever Therapy) (NCT00523679) | AstraZeneca | 2007-07-01 |
| Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD (NCT00489853) | AstraZeneca | 2007-07-01 |
| Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients (NCT00727883) | AstraZeneca | 2007-07-01 |
| Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan (NCT00516438) | AstraZeneca | 2007-07-01 |
| Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler (NCT00524641) | AstraZeneca | 2007-07-01 |
| Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets (NCT00536965) | AstraZeneca | 2007-07-01 |
| Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease (NCT00501111) | AstraZeneca | 2007-07-01 |
| Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder (NCT00457899) | AstraZeneca | 2007-07-01 |
| A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00500318) | AstraZeneca | 2007-07-01 |
| Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel (NCT00516724) | AstraZeneca | 2007-06-22 |
| Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer (NCT00494234) | AstraZeneca | 2007-06-15 |
| Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer (NCT00494442) | AstraZeneca | 2007-06-11 |
| Predictors of Recurrence in Bipolar Disorder in Spain (NCT00690859) | AstraZeneca | 2007-06-01 |
| A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients (NCT00500370) | AstraZeneca | 2007-06-01 |
| A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX (NCT00494221) | AstraZeneca | 2007-06-01 |
| Quetiapine Efficacy in Bipolar Depression Study (NCT00523601) | AstraZeneca | 2007-06-01 |
| A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART (NCT00503061) | AstraZeneca | 2007-06-01 |
| Interaction Between ABT-335, Rosuvastatin and Warfarin (NCT00487136) | AstraZeneca | 2007-06-01 |
| Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia (NCT00690365) | AstraZeneca | 2007-06-01 |
| National Survey on Infiltrative Breast Cancer (NCT00696527) | AstraZeneca | 2007-06-01 |
| COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus (NCT00526279) | AstraZeneca | 2007-06-01 |
| Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes) (NCT00526552) | AstraZeneca | 2007-06-01 |
| Observational Study on Costs and Caregiver Burden in Alzheimer's Disease (NCT00698165) | AstraZeneca | 2007-06-01 |
| Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis (NCT00859287) | AstraZeneca | 2007-06-01 |
| Quality Of Life While Receiving Faslodex (NCT00643513) | AstraZeneca | 2007-06-01 |
| Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan (NCT00473616) | AstraZeneca | 2007-05-01 |
| Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION (NCT00526721) | AstraZeneca | 2007-05-01 |
| Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD. (NCT00496470) | AstraZeneca | 2007-05-01 |
| Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention (NCT00689377) | AstraZeneca | 2007-05-01 |
| Seroquel Long-Term NIS for Schizophrenia Patients (NCT00523783) | AstraZeneca | 2007-05-01 |
| A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes (NCT00467649) | AstraZeneca | 2007-05-01 |
| FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis (NCT00486798) | AstraZeneca | 2007-05-01 |
| APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire) (NCT00523315) | AstraZeneca | 2007-05-01 |
| Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours (NCT00475956) | AstraZeneca | 2007-05-01 |
| Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity (NCT00689208) | AstraZeneca | 2007-05-01 |
| Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension ) (NCT00526708) | AstraZeneca | 2007-05-01 |
| Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France (NCT00681369) | AstraZeneca | 2007-05-01 |
| Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts (NCT00523484) | AstraZeneca | 2007-05-01 |
| A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus (NCT00477581) | AstraZeneca | 2007-05-01 |
| Study of an Extended Release (ER) Tablet, Single and Repeated Dosing (NCT00689039) | AstraZeneca | 2007-04-01 |
| Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602) (NCT00807053) | AstraZeneca | 2007-04-01 |
| A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia (NCT00463606) | AstraZeneca | 2007-04-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 (NCT00471367) | AstraZeneca | 2007-04-01 |
| A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler® (NCT00532922) | AstraZeneca | 2007-04-01 |
| Phase 3/Safety & Efficacy of Esomeprazole in Infants (NCT00468559) | AstraZeneca | 2007-04-01 |
| AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies (NCT00463814) | AstraZeneca | 2007-03-08 |
| A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. (NCT00378482) | AstraZeneca | 2007-03-05 |
| Statins and Risk of Myocardial Infarction in Real Life in France (NCT00679575) | AstraZeneca | 2007-03-01 |
| Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients (NCT00444275) | AstraZeneca | 2007-03-01 |
| AZD8330 First Time in Man in Patients With Advanced Malignancies (NCT00454090) | AstraZeneca | 2007-03-01 |
| Local Phase 4 Pan-European SMART Study (NCT00463866) | AstraZeneca | 2007-03-01 |
| Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD (NCT00524355) | AstraZeneca | 2007-03-01 |
| Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies (NCT00460460) | AstraZeneca | 2007-03-01 |
| Phase I Study in Patients With Solid Tumours (NCT00496028) | AstraZeneca | 2007-03-01 |
| A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects (NCT00449527) | AstraZeneca | 2007-03-01 |
| AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. (NCT00454805) | AstraZeneca | 2007-03-01 |
| A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects (NCT00449501) | AstraZeneca | 2007-03-01 |
| Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers (NCT00733265) | AstraZeneca | 2007-02-01 |
| Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (NCT00441727) | AstraZeneca | 2007-02-01 |
| Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes (NCT00434954) | AstraZeneca | 2007-02-01 |
| Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD) (NCT00837629) | AstraZeneca | 2007-02-01 |
| TLESR-impedance Study in Patients (NCT00743444) | AstraZeneca | 2007-02-01 |
| Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00435760) | AstraZeneca | 2007-02-01 |
| C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients (NCT00688454) | AstraZeneca | 2007-02-01 |
| Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation (NCT00684307) | AstraZeneca | 2007-02-01 |
| InPractice Survey on the Treatment of Hypercholesterolemia (NCT00523796) | AstraZeneca | 2007-02-01 |
| A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. (NCT00419952) | AstraZeneca | 2007-02-01 |
| Phase 3 /Seroquel SR Acute Mania Monotherapy - US (NCT00422123) | AstraZeneca | 2007-01-01 |
| Effectiveness of Anti-Psychotic in GPs Setting (NCT00543088) | AstraZeneca | 2007-01-01 |